Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ENDOMETRIAL NEOPLASMS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Large-scale testing (Phase 3)Looking for participantsNCT06379113
What this trial is testing

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Who this might be right for
Endometrial NeoplasmsAtypical Endometrial HyperplasiaProgesterone Resistance+1 more
Xiaojun Chen 29
Testing effectiveness (Phase 2)Study completedNCT00910091
What this trial is testing

The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Ipsen 73
Not applicableStudy completedNCT00340210
What this trial is testing

Extended Follow-up of Columbia, MO Serum Bank Participants

Who this might be right for
Breast CancerEndometrial CancerOvarian Cancer
National Cancer Institute (NCI) 6,720
Not applicableActive Not RecruitingNCT01977274
What this trial is testing

Predictive Clinical and Biological Parameters in Gynecological Cancer

Who this might be right for
Ovarian CancerEndometrium CancerCervix Cancer
Institut Paoli-Calmettes 300
Not applicableStudy completedNCT05796518
What this trial is testing

Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors

Who this might be right for
Endometrial CancerSurvivorship
Wake Forest University Health Sciences 44
Very early researchLooking for participantsNCT05691010
What this trial is testing

Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

Who this might be right for
Endometrial CancerStage III Endometrial CancerStage III Endometrial Carcinoma+2 more
Memorial Sloan Kettering Cancer Center 28
Large-scale testing (Phase 3)Ended earlyNCT00577317
What this trial is testing

Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer

Who this might be right for
LymphedemaStage 0 Cervical CancerStage 0 Uterine Corpus Cancer+16 more
Gynecologic Oncology Group 2
Testing effectiveness (Phase 2)Ended earlyNCT00470067
What this trial is testing

Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer

Who this might be right for
Endometrial Cancer
Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)Ended earlyNCT04527900
What this trial is testing

The UPPROACH (Upfront Intensity Modulated Proton Beam Therapy) Approach

Who this might be right for
Endometrial Cancer
University of Maryland, Baltimore 2
Large-scale testing (Phase 3)Study completedNCT00002764
What this trial is testing

Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma

Who this might be right for
Endometrial CancerKidney CancerMetastatic Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 340
Early research (Phase 1)Not Yet RecruitingNCT07807345
What this trial is testing

Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic

Who this might be right for
Head & Neck Squamous Cell CarcinomaNon-Small Cell Lung CancerEsophageal Cancer+5 more
Sutro Biopharma, Inc. 285
Not applicableLooking for participantsNCT07124000
What this trial is testing

DESTINY-PANTUMOUR04

Who this might be right for
Adenocarcinoma (NOS)Anal CancerBladder Cancer+24 more
AstraZeneca 100
Testing effectiveness (Phase 2)UnknownNCT01770171
What this trial is testing

Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer

Who this might be right for
Stage III-IV or Recurrent Endometrial Cancer
Catholic University of the Sacred Heart 108
Early research (Phase 1)Ended earlyNCT05229900
What this trial is testing

SGN-ALPV in Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsCarcinoma, Non-Small-Cell Lung+4 more
Seagen Inc. 43
Large-scale testing (Phase 3)Ended earlyNCT00566644
What this trial is testing

Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome

Who this might be right for
Endometrial CancerHereditary Non-polyposis Colon Cancer (hmsh2, hmlh1, hpms1, hpms2)
St George's, University of London 600
Testing effectiveness (Phase 2)Study completedNCT00739830
What this trial is testing

Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)

Who this might be right for
Endometrial Cancer
Merck Sharp & Dohme LLC 130
Testing effectiveness (Phase 2)Looking for participantsNCT01174121
What this trial is testing

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

Who this might be right for
Metastatic Colorectal CancerMetastatic Pancreatic CancerMetastatic Ovarian Cancer+2 more
National Cancer Institute (NCI) 332
Early research (Phase 1)Ended earlyNCT05827614
What this trial is testing

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

Who this might be right for
Triple Negative Breast Cancer (TNBC)High Grade Serous Ovarian CarcinomaHigh Grade Endometrial Carcinoma+9 more
Boundless Bio, Inc. 85
Testing effectiveness (Phase 2)Active Not RecruitingNCT06129604
What this trial is testing

Pilot Window of Opportunity Trial (POET)

Who this might be right for
Colorectal Carcinoma (CRC)Endometrial Carcinoma (EC)
University of Oklahoma 10
Next Page